Venture Summit Virtual Connect | Global 21

Venture Summit Virtual Connect | Global 21, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of venture...

QB3 Webinar: David Baker, University of Washington

Billions of years of evolution have proteins that perform incredibly specialized functions. But evolution must take a continuous path. What if, given all we now know about how structure relates...

2021 BTBA Virtual Annual Symposium

Hosted by Boston Taiwanese Biotechnology Association (BTBA) for biotech professionals in academia or industry to learn and connect virtually Boston Taiwanese Biotechnology Association (BTBA) will hold the 2021 BTBA Virtual...

Biotech CEO Summit

Held annually in Napa and Europe, the Biotech CEO Summits provide high-value, relationship-building opportunities through informal discussions where personal knowledge, insights, and ideas are exchanged with peers. These candid discussions...

2021 STAT Breakthrough Science Summit

Come here for the cutting edge Technologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit will take you...

Insights: Immunotherapy – Helping Our Bodies Cure Cancer

Community Relations Special Event Partnership Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of...

The pivotal role of CMC in the drug approval process

Solid state chemistry, polymorphic forms of the drug and the ability to scale up manufacturing are very important details that define the identity as well as feasibility of a drug....

Unstoppable: The Future of Biotech & Digital Health Investing

COVID-19 has ignited biotech and digital health investment activity – from telemedicine to drug trial technology to precision genomics. In 2020, biotech IPO’s continued to pique investor interest and venture capital fundraising...